Uterine artery Doppler and sFlt-1/PlGF ratio: Prognostic value in early-onset pre-eclampsia

Ultrasound in Obstetrics and Gynecology

Volumn 43, Issue 5, 2014, Pages 525-532

  Gomez Arriaga P I ^a   Herraiz, I ^a   Lopez Jimenez E A ^a   Escribano, D ^a   Denk, B ^b   Galindo, A ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

early onset pre eclampsia; placental growth factor; prognosis; soluble fms like tyrosine kinase 1; uterine arteries

Indexed keywords

BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN; PLACENTA PROTEIN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

BLOOD; DOPPLER ECHOGRAPHY; ECHOGRAPHY; FEMALE; HUMAN; MALE; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY; PROGNOSIS; PULSATILE FLOW; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; TIME; UTERINE ARTERY; VALIDATION STUDY;

BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTERS; PROGNOSIS; PULSATILE FLOW; REPRODUCIBILITY OF RESULTS; ROC CURVE; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, PULSED; UTERINE ARTERY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84899968564     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.13224     Document Type: Article

References (24)

1. Raymond D, Peterson E,. A critical review of early-onset and late-onset pre-eclampsia. Obstet Gynecol Surv 2011; 66: 497-506.
2. Catov JM, Ness RB, Kip KE, Olsen J,. Risk of early or severe pre-eclampsia related to pre-existing conditions. Int J Epidemiol 2007; 36: 412-419.
3. Bombrys AE, Barton JR, Habli M, Sibai BM,. Expectant management of severe preeclampsia at 27(0/7) to 33(6/7) weeks' gestation: maternal and perinatal outcomes according to gestational by weeks at onset of expectant management. Am J Perinatol 2009; 26: 441-446.
4. Bombrys AE, Barton JR, Nowacki EA, Habli M, Pinder L, How H, Sibai BM,. Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol 2008; 199: 247.e1-6.
5. Magee LA, Helewa ME, Moutquin JM, von Dadelszen P,. SOGC guidelines; diagnosis, evaluation and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008; 30 (Suppl): 1-48.
6. Côté AM, Firoz T, Mattman A, Lam EM, von Dadelszen P, Magee LA,. The 24-hour urine collection: gold standard or historical practice ? Am J Obstet Gynecol 2008; 199: 625.e1-6.
7. Menzies J, Magee LA, Macnab YC, Ansermino JM, Li J, Douglas MJ, Gruslin A, Kyle P, Lee SK, Moore MP, Moutquin JM, Smith GN, Walker JJ, Walley KR, Russell JA, von Dadelszen P,. Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes. Hypertens Pregnancy 2007; 26: 447-462.
8. Meler E, Figueras F, Mula R, Crispi F, Benassar M, Gõmez O, Gratacõs E,. Prognostic role of uterine artery Doppler in patients with preeclampsia. Fetal Diagn Ther 2010; 27: 8-13.
9. Kafkasli A, Türkçüoǧlu I, Turhan U,. Maternal, fetal and perinatal characteristics of preeclampsia cases with and without abnormalities in uterine artery Doppler indexes. J Matern Fetal Neonatal Med 2013; 26: 936-940.
10. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H,. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 2012; 206: 58.e1-8.
11. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H,. An automated method for the determination of the sFlt-1/PlGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 2010; 202: 161.e1-e11.
12. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM,. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: IX-XIV.
13. Sibai BM, Barton JR,. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol 2007; 196: 514.e1-9.
14. Baschat AA, Gembruch U,. The cerebroplacental Doppler ratio revisited. Ultrasound Obstet Gynecol 2003; 21: 124-127.
15. Figueras F, Meler E, Iraola A, Eixarch E, Coll O, Figueras J, Francis A, Gratacõs E, Gardosi J,. Customized birthweight standards for a Spanish population. Eur J Obstet Gynecol Reprod Biol 2008; 136: 20-24.
16. Verburg BO, Steegers EAP, De Ridder M, Snijders RJM, Smith E, Hofman A, Moll HA, Jaddoe VWV, Witteman JCM,. New charts for ultrasound dating of pregnancy and assessment of fetal growth: longitudinal data from a population-based study. Ultrasound Obstet Gynecol 2008; 31: 388-396.
17. Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM,. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155: 501-509.
18. SEGO. Protocolos Asistenciales en Obstetricia. Trastornos hipertensivos del embarazo 2006. http://www.sego.es. [Accessed 20 June 2013].
19. Gõmez Arriaga PI, Herraiz I, Lõpez-Jimenez EA, Gõmez-Montes E, Denk B, Galindo A,. Uterine artery Doppler and sFlt-1/PlGF ratio: usefulness in diagnosis of pre-eclampsia. Ultrasound Obstet Gynecol 2013; 41: 530-537.
20. Gõmez O, Figueras F, Fernández S, Bennasar M, Martínez JM, Puerto B, Gratacõs E,. Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynecol 2008; 32: 128-132.
21. Haddad B, Sibai BM,. Expectant management in pregnancies with severe pre-eclampsia. Semin Perinatol 2009; 33: 143-151.
22. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA,. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012; 125: 911-919.
23. Silasi M, Cohen B, Karumanchi SA, Rana S,. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am 2010; 37: 239-253.
24. Schoofs K, Grittner U, Engels T, Pape J, Denk B, Henrich W, Verlohren S,. The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction. J Perinat Med 2014; 42: 61-68.